Fresenius has expanded European intravenous fluids production across two countries. The €54 million programme adds manufacturing and warehouse capacity in Poland and Italy to strengthen regional supply.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Fresenius Kabi has launched a new production line for infusion fluids in Kutno. The investment, worth approximately PLN 100 million, is intended to increase the plant's production capacity and strengthen the supply of products used in hospital treatment in Poland and other European countries.